Literature DB >> 1704605

Distinctive response of arrhythmogenic right ventricular disease to high dose isoproterenol.

M Haissaguerre1, P Le Métayer, C D'Ivernois, J L Barat, P Montserrat, J F Warin.   

Abstract

Arrhythmogenic right ventricular disease is a potential cause of ventricular arrhythmias. Diagnosis is important due to the risk of sudden death, particularly as first symptom. Diagnosis is based on the angiographic demonstration of abnormal right ventricular morphology and function, while the sensitivity of noninvasive tests is relatively low. Following a particular observation studied in 1984, we prospectively assessed the diagnostic value of high dose isoproterenol infusion in 44 patients with an angiographically determined arrhythmogenic right ventricle. A continuous infusion of isoproterenol (8-30 micrograms/min) was administered during a 3-minute period, regardless of the obtained heart rate. In a control group of 50 patients without structural heart disease, isoproterenol induced a monomorphic ventricular tachycardia salvo in only one patient (2%). In patients with an arrhythmogenic right ventricle, isoproterenol induced one or more ventricular tachycardia runs in 39/44 cases (88%): one triplet in three patients, several runs in 23 patients and a sustained ventricular tachycardia in 13 patients. Arrhythmia was polymorphous in 85% of cases, but left bundle branch block morphology was the predominant pattern. In conclusion, high dose isoproterenol is a highly sensitive test for the diagnosis of arrhythmogenic right ventricular disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1704605     DOI: 10.1111/j.1540-8159.1990.tb06954.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

Review 1.  Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Pietro Turrini; Domenico Corrado; Cristina Basso; Andrea Nava; Gaetano Thiene
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

Review 2.  Utility of SAECG in arrhythmogenic right ventricle dysplasia.

Authors:  Khurram Nasir; Julie Rutberg; Harikrishna Tandri; Ronald Berger; Gordon Tomaselli; Hugh Calkins
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.